Pfizer on Tuesday became the latest major drugmaker to sell medicine directly to consumers, launching a digital platform that’s initially directed at people with migraines and respiratory ailments, including COVID-19.Why it matters: The move puts Pfizer in competition with Eli Lilly, which in January launched its own D2C platform to provide prescriptions for conditions like obesity…
Read More